BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 22927248)

  • 21. Salivary-gland-protective regulatory T-cell dysfunction underlies female-specific sialadenitis in the non-obese diabetic mouse model of Sjögren syndrome.
    Barr JY; Wang X; Kreiger PA; Lieberman SM
    Immunology; 2018 Oct; 155(2):225-237. PubMed ID: 29750331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reciprocal relation between GADD153 and Del-1 in regulation of salivary gland inflammation in Sjögren syndrome.
    Baban B; Liu JY; Abdelsayed R; Mozaffari MS
    Exp Mol Pathol; 2013 Dec; 95(3):288-97. PubMed ID: 24060278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome.
    Kim JW; Kim SM; Park JS; Hwang SH; Choi J; Jung KA; Ryu JG; Lee SY; Kwok SK; Cho ML; Park SH
    Arthritis Res Ther; 2019 Jun; 21(1):136. PubMed ID: 31164166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of age-related salivary gland autoimmunity by glycosylation-dependent galectin-1-driven immune inhibitory circuits.
    Martínez Allo VC; Hauk V; Sarbia N; Pinto NA; Croci DO; Dalotto-Moreno T; Morales RM; Gatto SG; Manselle Cocco MN; Stupirski JC; Deladoey Á; Maronna E; Marcaida P; Durigan V; Secco A; Mamani M; Dos Santos A; Catalán Pellet A; Pérez Leiros C; Rabinovich GA; Toscano MA
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6630-6639. PubMed ID: 32161138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.
    Kim D; Kim JY; Jun HS
    Oncotarget; 2016 Dec; 7(49):80298-80312. PubMed ID: 27880731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment for salivary gland hypofunction at both initial and advanced stages of Sjögren-like disease: a comparative study of bone marrow therapy versus spleen cell therapy with a 1-year monitoring period.
    Khalili S; Faustman DL; Liu Y; Sumita Y; Blank D; Peterson A; Kodama S; Tran SD
    Cytotherapy; 2014 Mar; 16(3):412-23. PubMed ID: 24411591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.
    Kern J; Drutel R; Leanhart S; Bogacz M; Pacholczyk R
    PLoS One; 2014; 9(11):e112467. PubMed ID: 25379761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-21-mediated suppression of the Pax3-Id3 pathway exacerbates the development of Sjögren's syndrome via follicular helper T cells.
    Park JS; Kim SM; Choi J; Jung KA; Hwang SH; Yang S; Kwok SK; Cho ML; Park SH
    Cytokine; 2020 Jan; 125():154834. PubMed ID: 31491724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
    Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
    Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulated Chemokine and Rho-GTPase Genes Define Immune Cell Emigration into Salivary Glands of Sjögren's Syndrome-Susceptible C57BL/6.NOD-
    Peck AB; Nguyen CQ; Ambrus JL
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucosal administration of alpha-fodrin inhibits experimental Sjögren's syndrome autoimmunity.
    He J; Zhao J; Li Z
    Arthritis Res Ther; 2008; 10(2):R44. PubMed ID: 18419828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CCL22-Producing Resident Macrophages Enhance T Cell Response in Sjögren's Syndrome.
    Ushio A; Arakaki R; Otsuka K; Yamada A; Tsunematsu T; Kudo Y; Aota K; Azuma M; Ishimaru N
    Front Immunol; 2018; 9():2594. PubMed ID: 30467506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase.
    Oak JS; Deane JA; Kharas MG; Luo J; Lane TE; Cantley LC; Fruman DA
    Proc Natl Acad Sci U S A; 2006 Nov; 103(45):16882-7. PubMed ID: 17071741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow cells are a source of undifferentiated cells to prevent Sjögren's syndrome and to preserve salivary glands function in the non-obese diabetic mice.
    Khalili S; Liu Y; Sumita Y; Maria OM; Blank D; Key S; Mezey E; Tran SD
    Int J Biochem Cell Biol; 2010 Nov; 42(11):1893-9. PubMed ID: 20732442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
    Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
    Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
    Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
    Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible function of salivary gland epithelial cells as nonprofessional antigen-presenting cells in the development of Sjögren's syndrome.
    Tsunawaki S; Nakamura S; Ohyama Y; Sasaki M; Ikebe-Hiroki A; Hiraki A; Kadena T; Kawamura E; Kumamaru W; Shinohara M; Shirasuna K
    J Rheumatol; 2002 Sep; 29(9):1884-96. PubMed ID: 12233883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defective selection of thymic regulatory T cells accompanies autoimmunity and pulmonary infiltrates in Tcra-deficient mice double transgenic for human La/Sjögren's syndrome-B and human La-specific TCR.
    Yaciuk JC; Pan Y; Schwarz K; Pan ZJ; Maier-Moore JS; Kosanke SD; Lawrence C; Farris AD
    J Immunol; 2015 Feb; 194(4):1514-22. PubMed ID: 25582858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Sjögren's Syndrome with Mesenchymal Stem Cells: A Systematic Review.
    Chihaby N; Orliaguet M; Le Pottier L; Pers JO; Boisramé S
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal stem cell transplantation alleviates Sjögren's syndrome symptoms by modulating Tim-3 expression.
    Sun T; Liu S; Yang G; Zhu R; Li Z; Yao G; Chen H; Sun L
    Int Immunopharmacol; 2022 Oct; 111():109152. PubMed ID: 36007392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.